Researchers Develop pH-Responsive Hydrogel for Oral Heparin
A new hybrid hydrogel enables targeted drug delivery by responding to pH changes in the gastrointestinal tract.
Updated on Oct. 30, 2026 in Chemistry
Live Poll
Do you trust that new lab-developed drug delivery methods will safely improve patient treatment outcomes?
Scientists have created an ultra-swelling hybrid hydrogel composed of chitosan, acrylic acid, and 2-hydroxyethyl methacrylate for oral heparin delivery. The material is designed to improve the stability and site-specific release of the medication within the gastrointestinal tract.
Why it matters
This development addresses the challenges of orally administering heparin, which typically requires injection due to its susceptibility to degradation. By ensuring the drug remains stable in acidic environments and releases effectively in neutral conditions, this technology could offer a more convenient delivery method for patients.
The hydrogel achieved a swelling ratio exceeding 4000% under near-neutral conditions while maintaining limited swelling in acidic media. The formulation was developed using low-temperature redox-initiated graft copolymerization and optimized via a Box-Behnken design.
The details
The hybrid hydrogel consists of chitosan, acrylic acid, and 2-hydroxyethyl methacrylate to manage drug release based on pH levels. Studies showed minimal heparin release during exposure to gastric pH, followed by rapid and sustained release once the material reached neutral to mildly alkaline environments.
Timeline
The research findings were published on October 30, 2026.
The Big Picture
This research contributes to the development of pH-responsive oral drug delivery systems, a field focused on bypassing the harsh gastric environment. It demonstrates how material science can be used to engineer controlled release mechanisms for drugs that are otherwise difficult to administer orally.
This advancement could eventually lead to oral heparin alternatives, potentially replacing traditional injectable methods for patients requiring long-term treatment. Success in these laboratory studies serves as a foundational step toward developing more accessible and less invasive medication administration protocols.
The takeaway
The study highlights how smart materials can be tailored to respond to the varying pH levels of the digestive system for safer drug release. These results provide a promising framework for future efforts to improve oral bioavailability of complex medications.
Further reading
Learn more about the latest innovations in this field in our Chemistry section.
Source note: This article includes information reported by Nature.
Live Poll
Do you trust that new lab-developed drug delivery methods will safely improve patient treatment outcomes?
